cas12071-sup-0001-FigS1.pdfPDF document327KFig. S1. Dose–response curves of 35 anticancer drugs.
cas12071-sup-0002-FigS2.pdfPDF document102KFig. S2. Hierarchical cluster analysis including RPMI8226 cell line data.
cas12071-sup-0003-FigS3.pdfPDF document102KFig. S3. KEGG pathway of “protein processing in endoplasmic reticulum”.
cas12071-sup-0004-TableS1.xlsapplication/msexcel39KTable S1. Upregulated and downregulated probe sets in each cluster of compounds.
cas12071-sup-0005-TableS2.xlsapplication/msexcel24KTable S2. Results of the Connectivity map for proteasome inhibitors.
cas12071-sup-0006-TableS3.xlsapplication/msexcel21KTable S3. Results of the connectivity scoring analysis for proteasome inhibitors.
cas12071-sup-0007-TableS4.xlsapplication/msexcel30KTable S4. Results of pathway analysis with the KEGG database.
cas12071-sup-0008-TableS5.xlsapplication/msexcel22KTable S5. Results of the connectivity scoring analysis for Hsp90 inhibitors.
cas12071-sup-0009-docS1.docWord document28KDoc S1. Supplementary methods.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.